Michael A. Proschan

Generating author description...

All published works

Action	Title	Year	Authors
+	Connections between Statistics and Mathematics/Probability	2025	Michael A. Proschan Pamela A. Shaw
+	Does Remdesivir Lower <scp>COVID</scp>‐19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen	2024	Gail E. Potter Michael A. Proschan
+	Rejoinder	2024	Diane Uschner Oleksandr Sverdlov Kerstine Carter Jonathan Chipman Olga Kuznetsova Jone Renteria Adam Lane Chris Barker Nancy L. Geller Michael A. Proschan
+	Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial	2024	Jungnam Joo Eric Leifer Michael A. Proschan James Troendle Harmony R. Reynolds Erinn A Hade Patrick R. Lawler Dong‐Yun Kim Nancy L. Geller
+ PDF Chat	Changing interim monitoring in response to internal clinical trial data	2024	Michael A. Proschan Martha Nason Ana M Ortega-Villa Jing Wang
+	The statistical design and analysis of pandemic platform trials: Implications for the future	2024	Christopher J. Lindsell Matthew S. Shotwell Kevin J. Anstrom Scott Berry Erica Brittain Frank E. Harrell Nancy L. Geller Birgit Grund Michael D. Hughes Prasanna Jagannathan
+ PDF Chat	The statistical design and analysis of pandemic platform trials: Implications for the future	2024	Leningrad Fh A N K-K A M E N E T Z K I J Matthew S. Shotwell A J Scott Berry Erica Brittain Harrell F.E Nancy L. Geller Birgit Grund Hughes M.D. Prasanna Jagannathan
+	Statistics of Rare Events	2023	Michael A. Proschan Yousra Kherabi
+	Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions	2023	Diane Uschner Oleksandr Sverdlov Kerstine Carter Jonathan Chipman Olga Kuznetsova Jone Renteria Adam Lane Chris Barker Nancy L. Geller Michael A. Proschan
+	Interpreting p-Values and Confidence Intervals Using Well-Calibrated Null Preference Priors	2022	Michael P. Fay Michael A. Proschan Erica Brittain Ram C. Tiwari
+	Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination	2022	Clarisa M. Buckner Lela Kardava Omar El Merhebi Sandeep Narpala Leonid Serebryannyy Bob C. Lin Wei Wang Xiaozhen Zhang Felipe Lopes de Assis Sophie Kelly
+	Noninferiority testing with censoring when the event rate is low	2022	Shannon Gallagher Jing Wang Keith Lumbard Lori E. Dodd Michael A. Proschan
+	A Note on Familywise Error Rate for a Primary and Secondary Endpoint	2022	Michael A. Proschan Dean Follmann
+	Data and Safety Monitoring Board Monitoring of Clinical Trials for Early Efficacy	2022	Lori E. Dodd Michael A. Proschan
+	Estimation and Hypothesis Testing	2022	Pamela A. Shaw Michael A. Proschan
+	A Practical Guide to Exact Confidence Intervals for a Distribution of Current Status Data Using the Binomial Approach	2022	Sungwook Kim Michael P. Fay Michael A. Proschan
+	Statistical Thinking in Clinical Trials	2021	Michael A. Proschan Julian Barreiro-Gomez
+	Design of Clinical Trials	2021	Michael A. Proschan Julian Barreiro-Gomez
+	Randomization-Based Inference	2021	Michael A. Proschan Julián Barreiro-Gomez
+ PDF Chat	Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment for binary, ordinal, and time‐to‐event outcomes”	2021	Michael A. Proschan
+ PDF Chat	Valid and Approximately Valid Confidence Intervals for Current Status Data	2021	Sungwook Kim Michael P. Fay Michael A. Proschan
+ PDF Chat	Diagnosing fraudulent baseline data in clinical trials	2020	Michael A. Proschan Pamela A. Shaw
+ PDF Chat	Two Stage Designs for Phase III Clinical Trials	2020	Dean Follmann Michael A. Proschan
+ PDF Chat	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan Sally Hunsberger Tyler Bonnett Mat Makowski
+ PDF Chat	The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design	2020	Munyaradzi Dimairo Philip Pallmann James Wason Susan Todd Thomas Jaki Steven A. Julious Adrian Mander Christopher J. Weir Franz Koenig Marc K. Walton
+ PDF Chat	The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design	2020	Munyaradzi Dimairo Philip Pallmann James Wason Susan Todd Thomas Jaki Steven A. Julious Adrian Mander Christopher J. Weir Franz Koenig Marc K. Walton
+	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan S. Hunsberger Tyler Bonnett Mat Makowski
+	A primer on strong vs weak control of familywise error rate	2020	Michael A. Proschan Erica Brittain
+	Estimation and Hypothesis Testing	2020	Pamela A. Shaw Michael A. Proschan
+	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan S. Hunsberger Tyler Bonnett Mat Makowski
+ PDF Chat	The Adaptive designs CONSORT Extension (ACE) Statement: A checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design	2019	Munyaradzi Dimairo Philip Pallmann James Wason Susan Todd Thomas Jaki Steven A. Julious Adrian Mander Christopher J. Weir Franz Koenig Marc K. Walton
+	Re‐randomization tests in clinical trials	2019	Michael A. Proschan Lori E. Dodd
+ PDF Chat	Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design	2018	Munyaradzi Dimairo Elizabeth Coates Philip Pallmann Susan Todd Steven A. Julious Thomas Jaki James Wason Adrian Mander Christopher J. Weir Franz Koenig
+	The Elements of Probability Theory	2018	Michael A. Proschan Pamela A. Shaw
+	Essentials of Probability Theory for Statisticians	2018	Michael A. Proschan Pamela A. Shaw
+	Valid and Approximately Valid Confidence Intervals for Current Status Data	2018	Sungwook Kim Michael P. Fay Michael A. Proschan
+	Intermediate Topics in Biostatistics	2017	Pamela A. Shaw Laura Lee Johnson Michael A. Proschan
+	Re-randomization tests for unplanned changes in clinical trials	2017	Michael A. Proschan
+ PDF Chat	Controlling the family-wise error rate in multi-arm, multi-stage trials	2017	Luis Alexander Crouch Lori E. Dodd Michael A. Proschan
+	Validity and power considerations on hypothesis testing under minimization	2016	Zhenzhen Xu Michael A. Proschan Shiowjen Lee
+	Response	2016	Michael A. Proschan Lori E. Dodd
+	Validity and power considerations on hypothesis testing under minimization	2016	Zhenzhen Xu Michael A. Proschan Shiowjen Lee
+ PDF Chat	Statistical considerations for a trial of Ebola virus disease therapeutics	2016	Michael A. Proschan Lori E. Dodd Dionne Price
+ PDF Chat	Two-part test of vaccine effect	2015	Zonghui Hu Michael A. Proschan
+ PDF Chat	Combining One-Sample Confidence Procedures for Inference in the Two-Sample Case	2014	Michael P. Fay Michael A. Proschan Erica Brittain
+	Multiple Comparisons ‐ Recent Advances	2014	Michael A. Proschan
+ PDF Chat	Connections between permutation and<i>t</i>-tests: relevance to adaptive methods	2014	Michael A. Proschan Ekkehard Glimm Martin Posch
+ PDF Chat	On the design and analysis of clinical trials with correlated outcomes	2014	Dean Follmann Michael A. Proschan
+	Multiple Comparisons	2014	Michael A. Proschan
+ PDF Chat	A modest proposal for dropping poor arms in clinical trials	2014	Michael A. Proschan Lori E. Dodd
+ PDF Chat	Pointwise confidence intervals for a survival distribution with small samples or heavy censoring	2013	Michael P. Fay Erica Brittain Michael A. Proschan
+ PDF Chat	Innovative Trial Designs to Improving Tuberculosis Drug Development	2012	Lori E. Dodd Michael A. Proschan
+ PDF Chat	Null but not void: considerations for hypothesis testing	2012	Pamela A. Shaw Michael A. Proschan
+ PDF Chat	Spending functions and continuous‐monitoring boundaries	2012	Michael A. Proschan K. K. Gordon Lan
+ PDF Chat	Unplanned adaptations before breaking the blind	2012	Martin Posch Michael A. Proschan
+	Intermediate Topics in Biostatistics	2012	Pamela A. Shaw Laura Lee Johnson Michael A. Proschan
+	A test of location for exchangeable multivariate normal data with unknown correlation	2011	Dean Follmann Michael A. Proschan
+	A Note on Correction of Information Time in a Survival Trial Using an Alpha Spending Function	2011	Michael A. Proschan Martha Nason
+ PDF Chat	Minimize the Use of Minimization with Unequal Allocation	2011	Michael A. Proschan Erica Brittain Lisa A. Kammerman
+	Does treatment effect depend on control event rate? Revisiting a meta-analysis of suicidality and antidepressant use in children	2010	Michael A. Proschan Erica Brittain Michael P. Fay
+ PDF Chat	Beyond the Quintessential Quincunx	2010	Michael A. Proschan Jeffrey S. Rosenthal
+	Sample size re‐estimation in clinical trials	2009	Michael A. Proschan
+	A Conditional Power Approach to the Evaluation of Predictive Power	2009	K. K. Gordon Lan Peter Hu Michael A. Proschan
+	Conditioning in 2 × 2 Tables	2008	Michael A. Proschan Martha Nason
+	Multiple Comparisons	2008	Michael A. Proschan
+	The Normal Approximation to the Binomial	2008	Michael A. Proschan
+	Self-Experimentation and Web Trials	2008	Michael A. Proschan
+	Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials	2007	Michael A. Proschan Dean Follmann
+	Discussions	2006	Michael A. Proschan
+	Statistical Monitoring of Clinical Trials: A Unified Approach	2006	Michael A. Proschan K. K. Gordan Lan Janet Wittes
+	Combining Treatment Selection and Definitive Testing	2006	Michael A. Proschan Sally Hunsberger
+	Clinical Trial Results Applied to Management of the Individual Cancer Patient	2006	Ismail Jatoi Michael A. Proschan
+	Statistical Monitoring of Clinical Trials	2006	Michael A. Proschan K. K. Gordan Lan Janet Wittes
+	Multiple Comparisons	2005	Michael A. Proschan
+	Two-Stage Sample Size Re-Estimation Based on a Nuisance Parameter: A Review	2005	Michael A. Proschan
+	Adaptive Regression	2005	Michael A. Proschan Eric Leifer Qing Liu
+	1. Multiple analyses in clinical trials: Fundamentals for investigators. Lemuel A. Moyé, Springer, New York, 2003. No. of pages: xxiii+436. Price: $79.95, £69.00. EUR 89.95. ISBN: 0‐387‐00727	2004	Michael A. Proschan
+	Adaptive Two-Stage Clinical Trials*	2003	Michael A. Proschan
+	Multiple Outputation: Inference for Complex Clustered Data by Averaging Analyses from Independent Data	2003	Dean Follmann Michael A. Proschan Eric Leifer
+	Practical midcourse sample size modification in clinical trials	2003	Michael A. Proschan Qing Liu Sally Hunsberger
+	Estimating the probability of toxicity at the target dose following an up‐and‐down design	2003	Mario Stylianou Michael A. Proschan Nancy Flournoy
+	THE GEOMETRY OF TWO-STAGE TESTS	2003	Michael A. Proschan
+	A Unified Theory of Two-Stage Adaptive Designs	2002	Qing Liu Michael A. Proschan Gordon Pledger
+	Sensitivity analysis using an imputation method for missing binary data in clinical trials	2001	Michael A. Proschan Robert P. McMahon Joanna H. Shih Sally Hunsberger Nancy L. Geller Genell L. Knatterud Janet Wittes
+	The Theory of Adaptation	2001	Qing Liu Michael A. Proschan Gordon Pledger
+	An Improved Double Sampling Procedure Based on the Variance	2000	Michael A. Proschan Janet Wittes
+	Practical Guidelines for Multiplicity Adjustment in Clinical Trials	2000	Michael A. Proschan Myron A. Waclawiw
+	Internal pilot studies I: type I error rate of the naivet-test	1999	Janet Wittes Oliver Schabenberger David M. Zucker Erica Brittain Michael A. Proschan
+	A Multivariate Test of Interaction for Use in Clinical Trials	1999	Dean Follmann Michael A. Proschan
+ PDF Chat	A Simple Permutation‐Type Method for Testing Circular Uniformity with Correlated Angular Measurements	1999	Dean Follmann Michael A. Proschan
+	A multiple comparison procedure for three- and four-armed controlled clinical trials	1999	Michael A. Proschan
+	Group Sequential Monitoring of Multi-Armed Clinical Trials	1999	Nancy L. Geller Michael A. Proschan Dean Follmann
+	STATISTICAL METHODS FOR MONITORING CLINICAL TRIALS	1999	Michael A. Proschan
+	Statistical Design of REACT (Rapid Early Action for Coronary Treatment), a Multisite Community Trial with Continual	1998	Henry A. Feldman Michael A. Proschan David M. Murray David C. Goff Mario Stylianou Eric M. Dulberg Paul G. McGovern Wenyaw Chan N. Clay Mann Vera Bittner
+	Editorial	1998	Lawrence M. Friedman Michael A. Proschan
+	A Restricted Test of Circadian Rhythm	1997	Michael A. Proschan Dean Follmann
+	A Restricted Test of Circadian Rhythm	1997	Michael A. Proschan Dean Follmann
+	Conditional power with Fisher's least significant difference procedure	1997	Michael A. Proschan
+	ON THE DISTRIBUTION OF THE UNPAIRED t-STATISTIC WITH PAIRED DATA	1996	Michael A. Proschan
+	Designed Extension of Studies Based on Conditional Power	1995	Michael A. Proschan Sally Hunsberger
+	67A Designed extension of studies based on conditional power	1995	Michael A. Proschan Sally Hunsberger
+	Multiple Comparisons with Control in a Single Experiment versus Separate Experiments: Why Do We Feel Differently?	1995	Michael A. Proschan Dean Follmann
+	Multiple Comparisons with Control in a Single Experiment versus Separate Experiments: Why Do We Feel Differently?	1995	Michael A. Proschan Dean Follmann
+	Group Sequential Monitoring of Multi-Armed Clinical Trials	1995	Nancy L. Geller Michael A. Proschan Dean Follmann
+	Monitoring multi‐armed trials	1994	Michael A. Proschan Dean Follmann Nancy L. Geller
+	Monitoring Pairwise Comparisons in Multi-Armed Clinical Trials	1994	Dean Follmann Michael A. Proschan Nancy L. Geller
+	Sample size calculation for clinical trials in which entry criteria and outcomes are counts of events	1994	Robert P. McMahon Michael A. Proschan Nancy L. Geller Peter H. Stone George Sopko
+	The effect of estimation and biasing strategies on selection bias in clinical trials with permuted blocks	1994	Dean Follmann Michael A. Proschan
+	Effects of Assumption Violations on Type I Error Rate in Group Sequential Monitoring	1992	Michael A. Proschan Dean Follmann Myron A. Waclawiw
+	A partial ordering of rank densities	1992	Michael A. Proschan Frederick W. Leysieffer
+ PDF Chat	A Note on Blackwell and Hodges (1957) and Diaconis and Graham (1981)	1991	Michael A. Proschan
+	The Use of Statistical Evidence in Allegations of Exam Cheating	1990	Philip J. Boland Michael A. Proschan

Common Coauthors

Coauthor	Papers Together
Dean Follmann	18
Lori E. Dodd	11
Nancy L. Geller	11
Erica Brittain	9
Pamela A. Shaw	9
Franz Koenig	7
Michael P. Fay	7
Thomas Jaki	7
Sally Hunsberger	6
Janet Wittes	5
Eric Leifer	5
Martin Posch	4
Philip Pallmann	4
Steven A. Julious	4
Toshimitsu Hamasaki	4
Daniel Hind	4
Douglas G. Altman	4
Katie Biggs	4
James Wason	4
Munyaradzi Dimairo	4
Susan Todd	4
Jon Nicholl	4
Marc K. Walton	4
John Scott	4
Qing Liu	4
Christopher J. Weir	4
Adrian Mander	4
Elizabeth Coates	4
Yukio Ando	4
Mat Makowski	3
Dean Follmann	3
Drifa Belhadi	3
Martha Nason	3
Tyler Bonnett	3
Sungwook Kim	3
Yeming Wang	3
Lisa L. Korn	3
William F. Rosenberger	2
Diane Uschner	2
Adam Lane	2
Giota Touloumi	2
France Mentré	2
Kerstine Carter	2
Prasanna Jagannathan	2
S. Hunsberger	2
Birgit Grund	2
K. K. Gordon Lan	2
Laura Lee Johnson	2
Christian Schoergenhofer	2
Lisa M. LaVange	2

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	A Multiple Testing Procedure for Clinical Trials	1979	Peter C. O’Brien Thomas R. Fleming	18
+	Group sequential methods in the design and analysis of clinical trials	1977	Stuart J. Pocock	17
+	Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance	1992	A. Lawrence Gould Weichung Joseph Shih	16
+	Statistical Monitoring of Clinical Trials: a Unified Approach	2007	Michael R. Chernick	14
+	Designed Extension of Studies Based on Conditional Power	1995	Michael A. Proschan Sally Hunsberger	13
+ PDF Chat	Adaptive Sample Size Calculations in Group Sequential Trials	1999	Walter Lehmacher Gernot Wassmer	12
+	Discrete sequential boundaries for clinical trials	1983	K. K. Gordon Lan David L. DeMets	11
+	Discrete Sequential Boundaries for Clinical Trials	1983	K. K. Gordon Lan David L. DeMets	11
+	Evaluation of Experiments with Adaptive Interim Analyses	1994	Péter Bauer Karl Kohne	10
+	Interim analyses for monitoring clinical trials that do not materially affect the type I error rate	1992	A. Lawrence Gould	10
+	Modification of Sample Size in Group Sequential Clinical Trials	1999	Lu Cui H. M. James Hung Sue‐Jane Wang	10
+	A Simple Sequentially Rejective Multiple Test Procedure	1979	Sture Holm	10
+	The role of internal pilot studies in increasing the efficiency of clinical trials	1990	Janet Wittes Erica Brittain	9
+	Sequential monitoring of clinical trials: The role of information and brownian motion	1993	K. K. Gordon Lan David M. Zucker	9
+	Stochastically curtailed tests in long–term clinical trials	1982	K. K. Gordon Lan Richard Simon Max Halperin	8
+	Repeated Significance Tests on Accumulating Data	1969	P. Armitage C. K. McPherson Beverley Charles Rowe	8
+	PLANNING AND REVISING THE SAMPLE SIZE FOR A TRIAL	1995	A. Lawrence Gould	7
+	Repeated assessment of results in clinical trials of cancer treatment	1971	J. L. Haybittle	7
+	A Multiple Comparison Procedure for Comparing Several Treatments with a Control	1955	Charles W. Dunnett	7
+	The B-Value: A Tool for Monitoring Data	1988	K. K. Gordon Lan Janet Wittes	7
+	Simultaneous Statistical Inference	1981	Rupert G. Miller	6
+	On closed testing procedures with special reference to ordered analysis of variance	1976	Ruth Marcus Eric Peritz K. R. Gabriel	6
+	An improved Bonferroni procedure for multiple tests of significance	1986	R. John Simes	6
+	A sharper Bonferroni procedure for multiple tests of significance	1988	Yosef Hochberg	6
+	Multiple Comparison Procedures	2013	Y. Hochberg Ajit C. Tamhane	6
+ PDF Chat	Unplanned adaptations before breaking the blind	2012	Martin Posch Michael A. Proschan	6
+ PDF Chat	A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection	2012	Dominic Magirr Thomas Jaki John Whitehead	6
+	Statistical Monitoring of Clinical Trials: A Unified Approach	2006	Michael A. Proschan K. K. Gordan Lan Janet Wittes	6
+	Internal pilot studies for estimating sample size	1994	Martin A. Birkett Simon Day	5
+	No Adjustments Are Needed for Multiple Comparisons	1990	Kenneth J. Rothman	5
+	Multiple Analyses in Clinical Trials	2003	Lemuel A. Moyé	5
+	Multivariate tests for multiple endpoints in clinical trials	1995	Dean Follmann	5
+	Group Sequential Methods with Applications to Clinical Trials	1999	Christopher Jennison Bruce W. Turnbull	5
+	Testing Whether an Identified Treatment Is Best	1989	Eugene Laska Morris Meisner	5
+	Effects of Assumption Violations on Type I Error Rate in Group Sequential Monitoring	1992	Michael A. Proschan Dean Follmann Myron A. Waclawiw	5
+	Multiple Comparisons with Control in a Single Experiment versus Separate Experiments: Why Do We Feel Differently?	1995	Michael A. Proschan Dean Follmann	5
+	Procedures for Comparing Samples with Multiple Endpoints	1984	Peter C. O’Brien	5
+	Monitoring clinical trials: Conditional or predictive power?	1986	David J. Spiegelhalter Laurence S. Freedman Patrick R. Blackburn	5
+	Optimal design of multi‐arm multi‐stage trials	2012	James Wason Thomas Jaki	5
+	Adaptive Designs for Randomized Trials in Public Health	2009	C. Hendricks Brown Rth Ho Booil Jo Getachew Dagne Peter A. Wyman Bengt Muthén Robert D. Gibbons	4
+	The advantages and disadvantages of adaptive designs for clinical trials	2004	Péter Bauer Werner Brannath	4
+	On inferences from Wei's biased coin design for clinical trials	1990	Colin B. Begg	4
+ PDF Chat	Speeding up the Evaluation of New Agents in Cancer	2008	Mahesh Parmar F. M.- S. Barthel Matthew R. Sydes Ruth E. Langley Richard Kaplan E. Eisenhauer Mark F. Brady Nicholas D. James Michael A. Bookman Ann Marie Swart	4
+	Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group	2006	Alan J. Phillips Oliver N. Keene	4
+	Practical Guidelines for Multiplicity Adjustment in Clinical Trials	2000	Michael A. Proschan Myron A. Waclawiw	4
+	A comparison of methods for adaptive sample size adjustment	2001	Tim Friede Meinhard Kieser	4
+	Asymptotic Statistics	1998	Aad van der Vaart	4
+	Secondary endpoints can be validly analyzed, even if the primary endpoint does not provide clear statistical significance	1997	C.E. Davis	4
+	Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group	2006	Paul Gallo Christy Chuang‐Stein Vladimir Dragalin Brenda Gaydos Michael Krams José Cirı́aco Pinheiro	4
+	Adaptive Two Stage Designs and the Conditional Error Function	1999	Martin Posch Péter Bauer	4